SIOG – International Society of Geriatric Oncology shared on LinkedIn:
“It is a well-known gap in geriatric oncology: the evidence guiding cancer care for older adults is largely built on trials that excluded them. A plenary session at SIOG 2026 on 6 November moves the conversation from problem to action.
Five presentations cover how drug development came to exclude older adults, what broader eligibility criteria and function-focused outcomes could look like in practice, the role of industry in advancing geriatric oncology, and how patient-reported outcomes can strengthen the evidence base.
Speakers join from Belgium, France, and the United States.
Learn more about the programme.”
